BACKGROUND: Obesity is a risk factor for cholesterol gallstone formation, but the pathogenesis of this phenomenon remains unclear. Most human obesity is associated with diabetes and leptin-resistance. Previous studies from this laboratory have demonstrated that diabetic leptin-resistant (Lep(db)) obese mice have low biliary cholesterol saturation indices, enlarged gallbladders and diminished gallbladder response to neurotransmitters. Recently, a novel leptin-resistant mouse strain Lepr(db-rtnd) (Rotund) has been discovered. Rotund mice are also obese, diabetic, and have an abnormal leptin receptor. Therefore, we tested the hypothesis that leptin-resistant obese Rotund mice would have large gallbladders and reduced biliary motility. METHODS: Eight-week-old control (C57BL/6J, N=12) and Rotund leptin-resistant (Lepr(db-rnd), N=9) mice were fed a non- lithogenic diet for four weeks. Animals were fasted and underwent cholecystectomy. Gallbladder volumes were recorded, and contractile responses (N/cm(2)) to acetylcholine (10(-5) M), Neuropeptide Y (10(-8,-7,-6) M), and cholecystokinin (10(-10,-9,-8,-7) M) were measured. Results were analyzed using the Mann-Whitney Rank Sum Test. RESULTS: Compared to control mice, Rotund mice had larger body weights, higher serum glucose levels, and greater gallbladder volumes (p<0.05). Rotund gallbladders had less contractility (p<0.05)) to acetylcholine and cholecystokinin than control mice. Responses to Neuropeptide Y were also less, but not statistically significant, in the Rotund mice. CONCLUSIONS: These data suggest that leptin-resistant Rotund mice have (1) enlarged gallbladders with (2) diminished contractility compared to lean control mice. Therefore, this study confirms that leptin-resistance is associated with abnormal biliary motility and may lead to gallstone formation in leptin-resistant obesity.
BACKGROUND:Obesity is a risk factor for cholesterol gallstone formation, but the pathogenesis of this phenomenon remains unclear. Most humanobesity is associated with diabetes and leptin-resistance. Previous studies from this laboratory have demonstrated that diabetic leptin-resistant (Lep(db)) obesemice have low biliary cholesterol saturation indices, enlarged gallbladders and diminished gallbladder response to neurotransmitters. Recently, a novel leptin-resistant mouse strain Lepr(db-rtnd) (Rotund) has been discovered. Rotund mice are also obese, diabetic, and have an abnormal leptin receptor. Therefore, we tested the hypothesis that leptin-resistant obese Rotund mice would have large gallbladders and reduced biliary motility. METHODS: Eight-week-old control (C57BL/6J, N=12) and Rotund leptin-resistant (Lepr(db-rnd), N=9) mice were fed a non- lithogenic diet for four weeks. Animals were fasted and underwent cholecystectomy. Gallbladder volumes were recorded, and contractile responses (N/cm(2)) to acetylcholine (10(-5) M), Neuropeptide Y (10(-8,-7,-6) M), and cholecystokinin (10(-10,-9,-8,-7) M) were measured. Results were analyzed using the Mann-Whitney Rank Sum Test. RESULTS: Compared to control mice, Rotund mice had larger body weights, higher serum glucose levels, and greater gallbladder volumes (p<0.05). Rotund gallbladders had less contractility (p<0.05)) to acetylcholine and cholecystokinin than control mice. Responses to Neuropeptide Y were also less, but not statistically significant, in the Rotund mice. CONCLUSIONS: These data suggest that leptin-resistant Rotund mice have (1) enlarged gallbladders with (2) diminished contractility compared to lean control mice. Therefore, this study confirms that leptin-resistance is associated with abnormal biliary motility and may lead to gallstone formation in leptin-resistant obesity.
Authors: Attila Nakeeb; Anthony G Comuzzie; Lisa Martin; Gabriele E Sonnenberg; Debra Swartz-Basile; Ahmed H Kissebah; Henry A Pitt Journal: Ann Surg Date: 2002-06 Impact factor: 12.969
Authors: Shannon J Graewin; James M Kiely; Keun-Ho Lee; Carol L Svatek; Attila Nakeeb; Henry A Pitt Journal: J Gastrointest Surg Date: 2004-11 Impact factor: 3.452
Authors: Matthew I Goldblatt; Deborah A Swartz-Basile; Carol L Svatek; Atilla Nakeeb; Henry A Pitt Journal: J Gastrointest Surg Date: 2002 May-Jun Impact factor: 3.452
Authors: Khoi Q Tran; Shannon J Graewin; Deborah A Swartz-Basile; Attila Nakeeb; Carol L Svatek; Henry A Pitt Journal: Surgery Date: 2003-08 Impact factor: 3.982
Authors: Shannon J Graewin; Keun-Ho Lee; James M Kiely; Carol L Svatek; Attila Nakeeb; Henry A Pitt Journal: Surgery Date: 2004-08 Impact factor: 3.982
Authors: Hayder H Al-Azzawi; Abhishek Mathur; Debao Lu; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt Journal: J Gastrointest Surg Date: 2007-01 Impact factor: 3.452